Distinguished in Movement Disorders

Shengdi Y. Chen

197 Rui Jin Er Road, 
Shanghai, CN 
Clinical Trials:Currently Recruiting for 1 Trial
Distinguished in Movement Disorders
197 Rui Jin Er Road, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Shengdi Chen practices in Shanghai, China. Chen is rated as a Distinguished expert by MediFind in the treatment of Movement Disorders. Their top areas of expertise are Parkinson's Disease, Movement Disorders, Essential Tremor, Thrombectomy, and Deep Brain Stimulation.

Their clinical research consists of co-authoring 233 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 115 articles in the study of Movement Disorders.

Locations

197 Rui Jin Er Road, Shanghai, 200025, China
Other Locations
Chinese Academy Of Medical Sciences And Peking Union Medical College, Beijing, 100730, China
1550 Haigang Street, Shanghai, 201306, China
Num 197, Ruijin 2nd Road, Shanghai, 200025, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease
A Phase II/III Multicenter Randomized, Double-Blind, Placebo-Controlled Platform Trial of Potential Disease Modifying Therapies Utilizing Biomarker, Cognitive, and Clinical Endpoints in Dominantly Inherited Alzheimer's Disease
Enrollment Status: Recruiting
Publish Date: August 01, 2025
Intervention Type: Drug
Study Drugs: Gantenerumab, Solanezumab
Study Phase: Phase 2/Phase 3

233 Total Publications

GABA outperforms iron and neuromelanin in detecting nigrostriatal alterations in early-stage Parkinson's disease with RBD.
GABA outperforms iron and neuromelanin in detecting nigrostriatal alterations in early-stage Parkinson's disease with RBD.
Journal: NPJ Parkinson's disease
Published: February 12, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Chen's expertise for a condition
ConditionClose
    View All 30 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile